Cargando…
Important role of 5‐hydroxytryptamine in glucocorticoid‐induced insulin resistance in liver and intra‐abdominal adipose tissue of rats
AIM/INTRODUCTION: Both glucocorticoids and 5‐hydroxytryptamine (5‐HT) have been shown to induce insulin resistance (IR) in hepatocytes and adipocytes. Here, we explore whether there is a correlation between them. MATERIALS AND METHODS: Except for the control group, male rats were exposed to dexameth...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718103/ https://www.ncbi.nlm.nih.gov/pubmed/26816599 http://dx.doi.org/10.1111/jdi.12406 |
_version_ | 1782410739771768832 |
---|---|
author | Li, Tao Guo, Keke Qu, Wei Han, Ying Wang, Shanshan Lin, Min An, Shanshan Li, Xin Ma, Shaoxin Wang, Tianying Ji, Shiya Hanson, Christian Fu, Jihua |
author_facet | Li, Tao Guo, Keke Qu, Wei Han, Ying Wang, Shanshan Lin, Min An, Shanshan Li, Xin Ma, Shaoxin Wang, Tianying Ji, Shiya Hanson, Christian Fu, Jihua |
author_sort | Li, Tao |
collection | PubMed |
description | AIM/INTRODUCTION: Both glucocorticoids and 5‐hydroxytryptamine (5‐HT) have been shown to induce insulin resistance (IR) in hepatocytes and adipocytes. Here, we explore whether there is a correlation between them. MATERIALS AND METHODS: Except for the control group, male rats were exposed to dexamethasone treated with or without para‐chlorophenylalanine (pCPA), or carbidopa for 20 days. Except for the control group, buffalo rat liver 3A (BRL‐3A) cells were exposed to dexamethasone for 24 h, treated with or without pCPA, carbidopa, or clorgiline for 48 h, or exposed to 5‐HT treated with or without fluoxetine for 48 h. Whole‐body IR was determined by both glucose tolerance test and measurement of fasting blood glucose and insulin, whereas hepatocytes or adipocytes IR was determined by examining either hepatic gluconeogenesis, steatosis and glucose transporter 2 expression or lipolysis. RESULTS: Dexamethasone‐induced whole‐body IR, liver and intraabdominal adipose IR were accompanied by upregulated expressions of tryptophan hydroxylase‐1 and aromatic amino acid decarboxylase with increased 5‐HT level in both tissues, which were attenuated significantly by pCPA, inhibiting tryptophan hydroxylase‐1, or carbidopa, inhibiting aromatic amino acid decarboxylase. [Correction added on 22 September 2015, after first online publication: ‘inhibiting aromatic amino acid decarboxylase’ was duplicated and has been replaced by ‘tryptophan hydroxylase‐1’.] In the BRL‐3A cells, dexamethasone‐induced IR was also accompanied by upregulated 5‐HT synthesis in dose‐ and time‐dependent manners, and was attenuated by pCPA or carbidopa, but exacerbated by clorgiline, inhibiting monoamine oxidase‐A to further increase 5‐HT level. Dexamethasone also enhanced 5‐HT 2A and 2B receptor expressions in both tissues and BRL‐3A cells. Additionally, blocking 5‐HT transporter with fluoxetine significantly suppressed 5‐HT‐induced IR in BRL‐3A cells. CONCLUSION: Enhancement of 5‐HT synthesis in liver and intra‐abdominal adipose is an important reason for glucocorticoids‐induced IR. |
format | Online Article Text |
id | pubmed-4718103 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-47181032016-01-26 Important role of 5‐hydroxytryptamine in glucocorticoid‐induced insulin resistance in liver and intra‐abdominal adipose tissue of rats Li, Tao Guo, Keke Qu, Wei Han, Ying Wang, Shanshan Lin, Min An, Shanshan Li, Xin Ma, Shaoxin Wang, Tianying Ji, Shiya Hanson, Christian Fu, Jihua J Diabetes Investig Articles AIM/INTRODUCTION: Both glucocorticoids and 5‐hydroxytryptamine (5‐HT) have been shown to induce insulin resistance (IR) in hepatocytes and adipocytes. Here, we explore whether there is a correlation between them. MATERIALS AND METHODS: Except for the control group, male rats were exposed to dexamethasone treated with or without para‐chlorophenylalanine (pCPA), or carbidopa for 20 days. Except for the control group, buffalo rat liver 3A (BRL‐3A) cells were exposed to dexamethasone for 24 h, treated with or without pCPA, carbidopa, or clorgiline for 48 h, or exposed to 5‐HT treated with or without fluoxetine for 48 h. Whole‐body IR was determined by both glucose tolerance test and measurement of fasting blood glucose and insulin, whereas hepatocytes or adipocytes IR was determined by examining either hepatic gluconeogenesis, steatosis and glucose transporter 2 expression or lipolysis. RESULTS: Dexamethasone‐induced whole‐body IR, liver and intraabdominal adipose IR were accompanied by upregulated expressions of tryptophan hydroxylase‐1 and aromatic amino acid decarboxylase with increased 5‐HT level in both tissues, which were attenuated significantly by pCPA, inhibiting tryptophan hydroxylase‐1, or carbidopa, inhibiting aromatic amino acid decarboxylase. [Correction added on 22 September 2015, after first online publication: ‘inhibiting aromatic amino acid decarboxylase’ was duplicated and has been replaced by ‘tryptophan hydroxylase‐1’.] In the BRL‐3A cells, dexamethasone‐induced IR was also accompanied by upregulated 5‐HT synthesis in dose‐ and time‐dependent manners, and was attenuated by pCPA or carbidopa, but exacerbated by clorgiline, inhibiting monoamine oxidase‐A to further increase 5‐HT level. Dexamethasone also enhanced 5‐HT 2A and 2B receptor expressions in both tissues and BRL‐3A cells. Additionally, blocking 5‐HT transporter with fluoxetine significantly suppressed 5‐HT‐induced IR in BRL‐3A cells. CONCLUSION: Enhancement of 5‐HT synthesis in liver and intra‐abdominal adipose is an important reason for glucocorticoids‐induced IR. John Wiley and Sons Inc. 2015-09-13 2016-01 /pmc/articles/PMC4718103/ /pubmed/26816599 http://dx.doi.org/10.1111/jdi.12406 Text en © 2015 The Authors. Journal of Diabetes Investigation published by Asian Association of the Study of Diabetes (AASD) and Wiley Publishing Asia Pty Ltd This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Articles Li, Tao Guo, Keke Qu, Wei Han, Ying Wang, Shanshan Lin, Min An, Shanshan Li, Xin Ma, Shaoxin Wang, Tianying Ji, Shiya Hanson, Christian Fu, Jihua Important role of 5‐hydroxytryptamine in glucocorticoid‐induced insulin resistance in liver and intra‐abdominal adipose tissue of rats |
title | Important role of 5‐hydroxytryptamine in glucocorticoid‐induced insulin resistance in liver and intra‐abdominal adipose tissue of rats |
title_full | Important role of 5‐hydroxytryptamine in glucocorticoid‐induced insulin resistance in liver and intra‐abdominal adipose tissue of rats |
title_fullStr | Important role of 5‐hydroxytryptamine in glucocorticoid‐induced insulin resistance in liver and intra‐abdominal adipose tissue of rats |
title_full_unstemmed | Important role of 5‐hydroxytryptamine in glucocorticoid‐induced insulin resistance in liver and intra‐abdominal adipose tissue of rats |
title_short | Important role of 5‐hydroxytryptamine in glucocorticoid‐induced insulin resistance in liver and intra‐abdominal adipose tissue of rats |
title_sort | important role of 5‐hydroxytryptamine in glucocorticoid‐induced insulin resistance in liver and intra‐abdominal adipose tissue of rats |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718103/ https://www.ncbi.nlm.nih.gov/pubmed/26816599 http://dx.doi.org/10.1111/jdi.12406 |
work_keys_str_mv | AT litao importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats AT guokeke importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats AT quwei importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats AT hanying importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats AT wangshanshan importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats AT linmin importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats AT anshanshan importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats AT lixin importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats AT mashaoxin importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats AT wangtianying importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats AT jishiya importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats AT hansonchristian importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats AT fujihua importantroleof5hydroxytryptamineinglucocorticoidinducedinsulinresistanceinliverandintraabdominaladiposetissueofrats |